Clinical trials are increasingly complex and expensive, meaning that RTSM forecasting technology has to evolve to keep up. Instead of the single forecasting algorithm which was previously used in all trials, modern RTSM platforms support a portfolio of forecasting algorithms to choose from. To leverage this technology, RTSM vendors are collaborating with sponsors to identify and implement the optimal forecasting setup for each trial